← Leaderboards
M. Teresa Magone
National Eye Institute
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Eye Institute
Same institution · by research overlap
Others in their field
Top investigators on “Outcome Measure”
- Paul S. Aisen · Cognition Therapeutics, Inc.$161,347,534
- Reisa A. Sperling · Banner Health$133,857,863
- Randall J Bateman · Washington University$124,655,201
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,065,597
- Eric Martin McDade · Washington University$96,219,353
- James E. Gern · University Of Wisconsin-Madison$90,069,547
Research focus
Outcome MeasureAge Related Macular DegenerationClinical ExaminationAutoimmuneAutologousAutologous TransplantationBiological MarkersBlindnessBlood TestsCalibrationCellsCell TherapyChemokineClinical CareAreaClinical ManagementClinical ResearchClinical TrialsClinic VisitsCohortCollectionCorneaCustomAffect
Grant awards (4)
A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular Degeneration$219,604
ZIA · FY2025 · EY · contact PI
Tear film biomarker testing from Schirmer strips as a clinical tool in autoimmune ocular surface disease$90,002
ZIA · FY2025 · EY · contact PI
A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated with Age-Related Macular Degeneration$248,146
ZIA · FY2024 · EY · contact PI
Tear film biomarker testing from Schirmer strips as a clinical tool in autoimmune ocular surface disease$101,699
ZIA · FY2024 · EY · contact PI